Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
donepezil hydrochloride, Quantity: 5 mg
Generic Health Pty Ltd
Donepezil hydrochloride
Tablet, film coated
Excipient Ingredients: macrogol 6000; maize starch; lactose monohydrate; titanium dioxide; purified talc; microcrystalline cellulose; sodium stearylfumarate; hypromellose; hyprolose
Oral
28, 84, 60, 112, 50, 56, 14, 120, 30, 98
(S4) Prescription Only Medicine
Donepezil is indicated for the treatment of mild, moderate and severe Alzheimer's disease.
Visual Identification: White to off white, circular biconvex, film-coated tablets, embossed with 'C' on one side and '7' on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius
Registered
2012-10-22
CONSUMER MEDICINE INFORMATION DONEPEZIL GH (DONEPEZIL HYDROCHLORIDE (AS MONOHYDRATE)) FILM-COATED TABLET WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Donepezil GH. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Donepezil GH against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT DONEPEZIL GH IS USED FOR Donepezil GH is used to treat mild, moderate and severe Alzheimer's disease, also called dementia of the Alzheimer's type. Donepezil GH will not cure this disease but should help your memory and improve your ability to think more clearly. This medicine belongs to a group of medicines called acetylcholinesterase inhibitors. They are thought to work by increasing the level of a chemical called acetylcholine in the brain. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. This medicine is not addictive. This medicine is only available with a doctor's prescription. _ _ _USE IN CHILDREN _ The safety and effectiveness of Donepezil GH in children has not been established. BEFORE YOU TAKE DONEPEZIL GH _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE DONEPEZIL GH IF YOU HAVE AN ALLERGY TO: • any medicine containing donepezil hydrochloride; • piperidine derivatives; • any of the ingredients listed at the end of this leaflet. Some of the symptoms of an allergic reaction may include: • shortness of breath; • wheezing or difficulty breathing; • swelling of the face, lips, tongue or other parts of the body; • rash, itching or hives on the skin. DO NOT TAKE THIS MEDICINE AFTER THE EXPIRY DATE PRINTED ON THE PACK OR IF THE PACKAGING IS TORN OR SHOWS SIGNS OF TAMPERING. If it has expired or Read the complete document
AUSTRALIAN PRODUCT INFORMATION – DONEPEZIL GH (DONEPEZIL HYDROCHLORIDE (AS MONOHYDRATE)) FILM-COATED TABLET 1 NAME OF THE MEDICINE Donepezil hydrochloride (as monohydrate). 2 QUALITATIVE AND QUANTITATIVE COMPOSITION DONEPEZIL GH film-coated tablets for oral administration are supplied containing 5 mg or 10 mg donepezil hydrochloride (as monohydrate) equivalent to 4.56 mg or 9.12 mg donepezil free base, respectively. List of excipients with known effects: lactose monohydrate. For the full list of excipients, see SECTION 6.1 LIST OF EXCIPIENTS. 3 PHARMACEUTICAL FORM DONEPEZIL GH 5 mg film-coated tablets: white to off white, circular, biconvex, film-coated tablets, embossed with ‘C’ on one side and ‘7’ on the other side. DONEPEZIL GH 10 mg film-coated tablets: yellow, circular, biconvex, film-coated tablets, embossed with ‘C’ on one side and ‘6’ on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS DONEPEZIL GH is indicated for the treatment of mild, moderate and severe Alzheimer’s disease. 4.2 DOSE AND METHOD OF ADMINISTRATION ADULTS/ELDERLY: Treatment should be initiated and supervised by a doctor experienced in the diagnosis and treatment of Alzheimer’s Dementia. Individual response to donepezil cannot be predicted. Treatment should be continued for as long as a therapeutic benefit for the patient exists. Discontinuation of therapy should be considered where there is no longer evidence of a therapeutic effect, which should be assessed by periodic evaluations by the physician using input from the patient and caregiver. The dosages of donepezil shown to be effective in controlled clinical trials are 5 mg and 10 mg administered once daily. Although there is no statistically significant evidence that a greater treatment effect is obtained from the use of the 10 mg dose, there is a suggestion, based on analysis of group data, that some additional benefits may accrue to some patients from the use of the higher dose. Donepezil GH v3.0 Page 2 of 25 (donepezil hydrochloride(as monohyd Read the complete document